IBC 2009
© IBC 2009. All Rights Reserved Contact Us
Friday, December 4
7 – 8:30 am Registration
8:30 – 9:30 am Opening Keynote Address
Drug Therapies for Neurodegenerative Diseases
Director of Eve Topf and NPFCenters of Excellence for Neurodegenerative Diseases Research
Haifa, Israel
9:30 – 10 am
Molecular Genetic Approaches to Axon Degeneration
The Brabraham Institute
Cambridge, United Kingdom
10 – 10:30 am Break
10:30 – 11 am
Diagnostic Issues in Neuropsychological Assessment of Older Adults: From Test Validity to Clinical Utility
Mayo Clinic
Jacksonville, Florida
11 – 11:30 am
Does the Ratio of Alzheimer A42 Production Alter in the Brains of Alzheimer’s Disease Patients?
Osaka University
Osaka, Japan
11:30 – 12 pm
Molecular Therapeutic for Alzheimer’s Disease
University of South Florida
Tampa, Florida
12 – 12:30 pm
Alzheimer’s disease Immunotherapy: From In Vitro Amyloid Immunomodulation to In Vivo Vaccination
Tel Aviv University
Tel Aviv, Israel
12:30 – 1:30 pm Lunch (On Your Own)
1:30 – 2 pm
An Analysis of Recent Research on Schizophrenia: Long-term Safety and Efficacy
Stanford University School of Medicine
Stanford, California
2 – 2:30 pm
Recent MRI Studies in Depression: Cause or Effect
Stanford University School of Medicine
Stanford, California
2:30 – 3 pm
Neuroplasticity in Development Disorders: New Treatment Targets
Joseph P. Horrigan, MD, FAACAP
Neurosciences Medicine Development Center
Research Triangle Park, North Carolina
3 – 3:30 pm Break
3:30 – 4 pm
Mechanical Circulatory Support, Heart Transplantation and Neurological Complications
Javier Lafuente, MD
Orlando, Florida
4 – 4:30 pm
Stem Cells: A New Hope for a Broken, Failing Heart
University of Minnesota Medical School
Minneapolis, Minnesota
4:30 – 5 pm
Neural Stem Cells for the Treatment of Alzheimer’s disease
University of California-Berkeley
Berkeley, California
5 – 6 pm Poster Session
7 – 9 pm An Evening with the Speakers
($50 for students and guests to attend)
Saturday, December 5
8:30 – 9:30 am Opening Keynote Address
IPS: The New Frontier in Regenerative Medicine
Mayo Clinic
Rochester, Minnesota
9:30 – 10 am
Depression and Inflammation: Implications for Depression as a Risk Factor for Medical Co-morbidity
Emory University School of Medicine
Atlanta, Georgia
10 – 10:30 am Break
10:30 – 11 am
The Diagnosis and Treatment of Dementia
Harvard Medical School, Mass General Hospital and McLean Hospital
Andover, Massachusetts
11 – 11:30 am
Neuropsychological Contributions to the Early Assessment of Alzheimer’s Disease
Arthur MacNeill Horton, Jr., EdD, ABPP, ABPN
Editor in Chief, Applied Neuropsychology
Bethesda, Maryland
11:30 – 12 pm
Early, Pre-morbid, Abeta Amyloid- induced Neuropathology of Alzheimer’s disease
McGill University
Montreal, Quebec, Canada
12 – 12:30 pm
LRRK2 Directing Stress Signaling
Boston University School of Medicine
Boston, Massachusetts
12:30 –1:30 pm Lunch (On Your Own)
1:30 – 2 pm
Behavioral and Psychological Risk Factors for Cardiovascular Disease
Pradip Jamnadas, MD, MBBS, FACC, FSCAL, FCCP, FACP
University of Central Florida College of Medicine
Orlando, Florida
2 – 2:30 pm
Strategies for Effective Stem–cell- based Therapy for Cardiac Repair
University of Cincinnati Medical Center
Cincinnati, Ohio
2:30 – 3 pm
Stem Cell and Cardiac Regeneration
Dinender Singla, MD, PhD, FAHA
University of Central Florida College of Medicine
Orlando, Florida
3 – 3:30 pm Break
3:30 – 4 pm
Markers Distinguishing Cancer Stem Cells from Normal Adult Neuronal Stem Cell Population in Malignant Gliomas
Florida Hospital Neuroscience Institute
Orlando, Florida
4 – 4:30 pm
Frontier of iPS Cells
University of Central Florida College of Medicine
Orlando, Florida
